GlaxoSmithKline Pakistan Limited reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was PKR 15,616.13 million compared to PKR 11,399.12 million a year ago. Net income was PKR 565.28 million compared to PKR 430.56 million a year ago.

Basic earnings per share from continuing operations was PKR 1.78 compared to PKR 1.35 a year ago.